vapiprost hydrochloride
vapiprost hydrochloride events and occlusive vascular disease. Phase III trials were underway in Japan for the treatment of deep vein thrombosis. Reference standards of Vapiprost Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Vapiprost Hydrochloride - API Standards
[catalogue_number] => PA 22 16000
[category_ids] => ,80,78,70,82,71,
[chemical_name] =>
[weight] => 514.10
[form] => C30H40ClNO4
[cas] => 87248-13-3
[pslug] => 87248-13-3-vapiprost-hydrochloride-api-pa2216000
[latest_product] => 0
[linkproducts] => 1
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Vapiprost Hydrochloride - API Standards
Catalogue No.:PA 22 16000
Molecular Formula : C30H40ClNO4
Molecular Weight : 514.10